Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2012 2
2013 1
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
Convergence Insufficiency Treatment Trial (CITT) Investigator Group and the Convergence Insufficiency Treatment Trial-Attention and Reading Trial (CITT-ART) Investigator Group. Convergence Insufficiency Treatment Trial (CITT) Investigator Group and the Convergence Insufficiency Treatment Trial-Attention and Reading Trial (CITT-ART) Investigator Group. Ophthalmic Physiol Opt. 2022 Nov;42(6):1412-1413. doi: 10.1111/opo.13052. Epub 2022 Sep 16. Ophthalmic Physiol Opt. 2022. PMID: 36111644 Free PMC article. No abstract available.
Does coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
Kulp MT, Sinnott LT, Cotter SA, Borsting E, Toole AJ, Chen AM, Jenewein EC, Morrison AM, Plaumann MD, Jones-Jordan L, Mitchell GL, Tea YC, Scheiman MM; Convergence Insufficiency Treatment Trial (CITT) Investigator Group; Convergence Insufficiency Treatment Trial - Attention, Reading Trial (CITT-ART) Investigator Group. Kulp MT, et al. Ophthalmic Physiol Opt. 2022 Jan;42(1):59-70. doi: 10.1111/opo.12911. Epub 2021 Nov 3. Ophthalmic Physiol Opt. 2022. PMID: 34730250 Free PMC article.
Validity of the convergence insufficiency symptom survey: a confirmatory study.
Rouse M, Borsting E, Mitchell GL, Cotter SA, Kulp M, Scheiman M, Barnhardt C, Bade A, Yamada T; Convergence Insufficiency Treatment Trial (CITT) Investigator Group. Rouse M, et al. Optom Vis Sci. 2009 Apr;86(4):357-63. doi: 10.1097/OPX.0b013e3181989252. Optom Vis Sci. 2009. PMID: 19289977 Free PMC article.
Effectiveness of placebo therapy for maintaining masking in a clinical trial of vergence/accommodative therapy.
Kulp M, Mitchell GL, Borsting E, Scheiman M, Cotter S, Rouse M, Tamkins S, Mohney BG, Toole A, Reuter K; Convergence Insufficiency Treatment Trial Study Group. Kulp M, et al. Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2560-6. doi: 10.1167/iovs.08-2693. Epub 2009 Jan 17. Invest Ophthalmol Vis Sci. 2009. PMID: 19151384 Free PMC article. Clinical Trial.